Passkey Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $22M

  • Investors
  • 6

Passkey Therapeutics General Information

Description

Operator of a biotechnology company intended to discover new medicines for complex diseases. The company focuses on discovering new medicines for complex, multifactorial diseases such as metabolic diseases and cancer by leveraging computational and genomic methods to facilitate drug discovery, enabling businesses to develop more effective treatments with potentially fewer side effects.

Contact Information

Website
www.passkeytx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Kendall Square
  • Building 200, Suite 001
  • Cambridge, MA 02139
  • United States
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • One Kendall Square
  • Building 200, Suite 001
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Passkey Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 28-Jun-2024 $22M Completed Startup
To view Passkey Therapeutics’s complete valuation and funding history, request access »

Passkey Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-3
Seed-2
Seed-1 3,333,850 $0.000100 8% $1.29 $1.29 1x $1.29 15.1%
To view Passkey Therapeutics’s complete cap table history, request access »

Passkey Therapeutics Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Passkey Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198907-A1 Systems and methods for identifying a ligand binding to products of a gene combination Pending 21-Mar-2025
US-20250232838-A1 Methods and systems for identifying and validating a gene combination associated with a trait and uses thereof Pending 17-Jan-2024
WO-2025155736-A1 Methods and systems for identifying and validating a gene combination associated with a trait and uses thereof Pending 17-Jan-2024 G16B20/20

Passkey Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Passkey Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Bison Ventures Venture Capital Minority
Breakout Ventures Venture Capital Minority
GRIDS Capital Venture Capital Minority
Innovation Endeavors Management Company Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Passkey Therapeutics FAQs

  • When was Passkey Therapeutics founded?

    Passkey Therapeutics was founded in 2022.

  • Where is Passkey Therapeutics headquartered?

    Passkey Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Passkey Therapeutics?

    Passkey Therapeutics has 14 total employees.

  • What industry is Passkey Therapeutics in?

    Passkey Therapeutics’s primary industry is Biotechnology.

  • Is Passkey Therapeutics a private or public company?

    Passkey Therapeutics is a Private company.

  • What is the current valuation of Passkey Therapeutics?

    The current valuation of Passkey Therapeutics is .

  • What is Passkey Therapeutics’s current revenue?

    The current revenue for Passkey Therapeutics is .

  • How much funding has Passkey Therapeutics raised over time?

    Passkey Therapeutics has raised $22M.

  • Who are Passkey Therapeutics’s investors?

    Alexandria Venture Investments, Bison Ventures, Breakout Ventures, GRIDS Capital, and Innovation Endeavors Management Company are 5 of 6 investors who have invested in Passkey Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process